经纬恒润(688326) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥708,803,467.37, representing a decrease of 2.71% compared to the same period last year[6] - The net profit attributable to shareholders of the listed company was -¥31,730,855.75, a decline of 198.16% year-on-year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥64,771,165.98, a decrease of 305.41% compared to the previous year[6] - Total revenue for Q1 2022 was approximately ¥708.80 million, a decrease of 2.7% compared to ¥728.58 million in Q1 2021[33] - Net profit for Q1 2022 was approximately -¥31.73 million, compared to a net profit of ¥32.33 million in Q1 2021, indicating a substantial decline[36] - Basic and diluted earnings per share for Q1 2022 were both -¥0.35, down from ¥0.36 in Q1 2021[37] - The company reported a total comprehensive income of approximately -¥32.16 million for Q1 2022, down from ¥32.26 million in Q1 2021[36] Research and Development - The total R&D investment amounted to ¥143,478,973.08, an increase of 61.36% year-on-year, accounting for 20.24% of operating revenue, up by 8.04 percentage points[9] - Research and development expenses rose significantly to approximately ¥143.48 million, an increase of 61.5% compared to ¥88.92 million in Q1 2021[33] Cash Flow and Liquidity - The net cash flow from operating activities was -¥130,109,091.07, which is not applicable for comparison[6] - Cash flow from operating activities showed a net outflow of approximately -¥130.11 million in Q1 2022, compared to -¥97.53 million in Q1 2021[37] - Total cash inflow from operating activities was approximately ¥632.38 million, an increase from ¥556.87 million in Q1 2021[37] - Total cash outflow from operating activities was approximately ¥762.49 million, up from ¥654.40 million in Q1 2021[37] - The cash flow from operating activities was not detailed, but the overall cash position indicates challenges in liquidity management[39] - The company reported a net decrease in cash and cash equivalents of -172,530,556.25, slightly worse than -171,241,434.02 in the previous period[39] - The ending balance of cash and cash equivalents was 749,049,654.70, down from 921,580,210.95 at the beginning of the period[39] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,581,409,981.75, an increase of 1.70% from the end of the previous year[9] - The equity attributable to shareholders of the listed company was ¥1,499,591,648.91, a decrease of 1.29% from the end of the previous year[9] - The company's current assets totaled CNY 3.38 billion, slightly up from CNY 3.37 billion year-over-year, indicating a growth of approximately 0.5%[24] - Total liabilities reached CNY 3.08 billion, up from CNY 2.99 billion, reflecting an increase of approximately 3.7%[29] - The company’s long-term liabilities totaled CNY 309.00 million, slightly up from CNY 301.85 million, reflecting an increase of about 2.5%[29] - The company reported a total current liability of CNY 2.77 billion, an increase from CNY 2.68 billion, indicating a growth of approximately 3.9%[29] Impact of External Factors - The company experienced a significant impact on net profit due to the COVID-19 pandemic and chip shortages, leading to a decline compared to the same period last year[12] - The company experienced a foreign exchange loss of -1,214,738.97, impacting the overall cash position[39]